Healthtech Startups

Valcare Medical develops transcatheter solutions for treating mitral regurgitation, a structural heart condition, aiming to provide surgical-level durability without open-heart surgery. The company's flagship system is designed for interventional cardiologists and patients requiring mitral valve repair.

1 investor

Valencia Technologies is a neuromodulation company that makes eCoin, an FDA-approved coin-sized tibial nerve implant for treating Urge Urinary Incontinence. The leadless neurostimulator is placed under the skin near the ankle in a minimally invasive procedure to provide drug-free bladder control therapy for patients.

1 investor

Valene Health develops enterprise workflow automation software using agentic AI and physician-built intelligence to streamline clinical and operational processes for healthcare organizations. The platform serves hospital systems, community health centers, and behavioral health clinics through pre-trained AI agents and no-code customization tools.

1 investor

VALFIX develops a transcatheter mitral valve repair system with a robotic interface, designed to convert open-heart valve surgery into a minimally invasive transcatheter procedure. The technology targets patients with mitral valve disease and heart failure.

1 investor

Vali provides an AI-assisted platform for karyotyping analysis, where users upload metaphase images and receive cytogenetic results within 24 hours. It serves cytogenetics labs and clinicians, combining artificial intelligence with expert review in the healthtech/diagnostics space.

1 investor

Validfor provides computerized system validation (CSV) software and consulting for the life sciences and pharmaceutical industry, covering validation management, data integrity, and quality assurance. It serves regulated companies needing to demonstrate compliance of their computerized systems.

1 investor

Validify offers an automated approach to computer system validation (CSV) and regulatory compliance, replacing manual validation processes. It targets teams responsible for staying compliant with regulation.

1 investor

Validproof provides a traceability and compliance platform for pharmaceutical companies to verify product origin, authenticity, and delivery status throughout the supply chain and prevent counterfeiting.

1 investor

Valio provides an AI platform that analyzes rebate contracts and purchase order history for health systems to identify unclaimed rebate savings, verify vendor payments, and optimize rebate distribution across hospitals.

1 investor

Valius is a molecular oncology company that develops tools to understand cancer cell behavior and enable targeted drug development and personalized therapies. It serves clinical and pharmaceutical organizations focused on improving cancer treatment outcomes.

1 investor

Valkyrie Industries develops EMS wearable bands (eir) that integrate with VR and mobile apps to support neuromuscular recovery in clinical and fitness settings. The technology enables real-time muscle activation feedback for functional therapy, rehabilitation, and performance training.

1 investor

Valor Vision turns a smartphone into a 3D biomechanics tool that gives athletes a movement profile, injury-risk asymmetry flags, and personalized training plans tracked from baseline through return to play. It serves professional and college sports teams, training facilities, coaches, trainers, and physical therapists for long-term athletic development.

1 investor

Valor Global is a customer experience and contact center outsourcing (BPO) provider that supplies trained support agents, training programs, and quality assurance for clients in sectors such as healthcare and dentistry. It operates across multiple global sites, including a training hub in Costa Rica, offering multichannel customer support, agent onboarding, and performance optimization services.

1 investor

Valora Therapeutics is a biotech company developing antibody-lectin chimera (AbLec) therapeutics that target cell-surface glycans for immuno-oncology and immunotherapy applications. Its work builds on glycobiology and bioorthogonal chemistry research.

1 investor

Valorum is a biosimilars company focused on commercializing biosimilar therapies with an emphasis on supply continuity, disciplined pricing, and buy-and-bill partnership models for physician practices, with an initial focus on oncology and ophthalmology. It serves clinicians and specialty care practices in the United States.

1 investor

ValoTx develops oncolytic virus-based immunotherapies that combine viral vector technology with peptide vaccination to treat cancer. The company leverages a patented platform to rapidly create personalized and disease-specific immunotherapies targeting multiple cancer types.

1 investor

Valtruis is a healthcare-focused investment firm that invests in and helps build companies changing how healthcare is accessed, delivered, experienced, and paid for. It provides portfolio companies with access to a network of health system leaders, payor executives, and operators, and is backed by Welsh, Carson, Anderson & Stowe.

1 investor

Vanda is a biopharmaceutical company that develops new medicines, using genetics and genomics to guide drug discovery, clinical trials, and commercial positioning of its compounds. It works to advance novel approaches for delivering these medicines to patients.

1 investor

Vandria is a pharmaceutical development company focused on translating scientific innovation into first-in-class therapeutics. The company's management team specializes in mitochondrial function and neurological disease treatment.

1 investor

Vantage Biosciences develops clinical-stage drug therapies for retinal and other diseases, with a focus on the AOC3 target and its role in liver and eye disease. The company works with a network of preclinical and clinical experts to advance therapeutics where existing treatment options are limited.

1 investor

Vantari provides VR-based procedural training for healthcare professionals, combining immersive simulation with AI-powered performance analytics and a community platform for medical education.

1 investor

Vapogenix is a pharmaceutical developer creating non-opioid pain relief therapies designed for rapid onset and long-lasting effect.

1 investor

Vara AI develops clinically validated AI tools for breast imaging that assist radiologists in detecting cancers earlier and improving diagnostic accuracy. The company integrates AI into real-world radiology workflows to enhance efficiency and consistency in breast cancer detection and diagnosis.

1 investor

Siemens Healthineers provides integrated technology solutions for cancer care, spanning screening, diagnosis, treatment planning, delivery, and survivorship support. The portfolio aims to coordinate fragmented workflows and simplify clinical decision-making across the cancer care continuum.

1 investor